Market capitalization | $4.05b |
Enterprise Value | $6.10b |
P/E (TTM) P/E ratio | 57.66 |
EV/FCF (TTM) EV/FCF | 85.36 |
EV/Sales (TTM) EV/Sales | 5.45 |
P/S ratio (TTM) P/S ratio | 3.62 |
P/B ratio (TTM) P/B ratio | 8.62 |
Revenue growth (TTM) Revenue growth | 13.11% |
Revenue (TTM) Revenue | $1.12b |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
8 Analysts have issued a Sotera Health Co forecast:
8 Analysts have issued a Sotera Health Co forecast:
Sep '24 |
+/-
%
|
||
Revenue | 1,120 1,120 |
13%
13%
|
|
Gross Profit | 556 556 |
17%
17%
|
|
EBITDA | 527 527 |
12%
12%
|
EBIT (Operating Income) EBIT | 361 361 |
14%
14%
|
Net Profit | 71 71 |
123%
123%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Sotera Health Co. provides sterilization and lab testing and advisory services to the medical device and pharmaceutical industries. It provides sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers. The company was founded in November 2017 and is headquartered in Broadview Heights, OH.
Head office | United States |
CEO | Michael Petras |
Employees | 3,000 |
Founded | 1978 |
Website | soterahealth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.